Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs

By Larry Ramer, InvestorPlace Contributor
The best weight-loss drug stocks are improving the drugs or developing new, potentially superior, weight-loss treatments.

3 Biotech Stocks to Sell in January Before They Crash and Burn

By Tomas Levani, InvestorPlace Contributor
The biotech industry is one of the most profitable though risky at the same time. Here are three biotech stocks to sell.

3 Small-Cap Healthcare Stocks to Buy and Hold Forever: January 2024

By Jeremy Flint, InvestorPlace Contributor
Small-cap healthcare stocks combine relative cheapness with advanced innovations including AI, automation, and more.

3 Cannabis Stocks to Buy in the ‘Green Zone’

By TradeSmith Research Staff
It's now time to take a look at these three cannabis stocks to buy, as each one is currently within TradeSmith's "Green Zone."

Why Is Processa Therapeutics (PCSA) Stock Up 90% Today?

By Josh Enomoto, InvestorPlace Contributor
Processa Pharmaceuticals successfully completed its safety trial for a key cancer drug. Now, PCSA stock is soaring on the positive implications.

The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs

By Stavros Tousios, InvestorPlace Contributor
Next gen biotech stocks such as Pfizer, Exscientia, and GSK leverage AI to drive biotech breakthroughs, shaping the future of the industry.

Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January

By Chandler Capital, InvestorPlace Contributor
These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions.

7 Over-Hyped Stocks to Sell Before They Plunge

By Louis Navellier and the InvestorPlace Research Staff
Maybe you’ve fallen for the hype and it's time to think about which stocks to sell. It’s easy to get excited about a stock with…

7 Dividend Stocks to Buy and Never Sell: January 2024 Edition

By Rich Duprey, InvestorPlace Contributor
Seeking out dividend stocks to buy and hold is a time-tested strategy that has proved itself in all types of markets.

3 Stocks to Buy for Long-Term Growth: 2024 Market Trends

By Josh Enomoto, InvestorPlace Contributor
Whenever the discussion pivots to stocks to buy for long-term growth, invariably, the “accretive” technology sector garners a tremendous amount of the spotlight. By accretive,…

3 Dividend Stars Every Investor Should Own to Survive a Market Crash

By Rich Duprey, InvestorPlace Contributor
Prepare for the worst but hope for the best by buying dividend stocks for a market crash that can provide both growth and income.

Why Is SciSparc (SPRC) Stock Up 50% Today?

By Josh Enomoto, InvestorPlace Contributor
News of an investment fund inking an equity purchase agreement with SciSparc is boosting underlying credibility and lifting SPRC stock.

3 Cash-Rich Stocks to Buy for Peace of MInd in 2024

By Will Ashworth, InvestorPlace Contributor
Cash-rich stocks are always good to hold for the long term. However, they’re a must in this high-interest rate environment.

3 Robotics Stocks to Buy and Hold Forever: January 2024

By Muslim Farooque, InvestorPlace Contributor
Wager on these top robotics stocks to buy as the industry kicks in to overdrive offering robust long-term upside.

Why Is Inovio Pharmaceuticals (INO) Stock Down Today?

By William White, InvestorPlace Writer
Inovio Pharmaceuticals stock is falling on Wednesday as the company prepares for a 1-for-12 reverse stock split for INO.

Why Is Evaxion Biotech (EVAX) Stock Up 30% Today?

By William White, InvestorPlace Writer
Evaxion Biotech stock is climbing higher on Wednesday alongside news of Merck acquiring shares of EVAX for an 11.4% stake in the company.

3 Blue-Chip Healthcare Stocks to Buy and Hold Forever: January 2024

By Jeremy Flint, InvestorPlace Contributor
Blue-chip healthcare stocks combine stability, profitability, and long-term growth prospects into a single investable package.

7 Beaten-Down Value Stocks Poised for an Epic Turnaround

By Omor Ibne Ehsan
Battered value stocks could be priced for an epic rebound in 2024 and beyond. These seven can quickly escape Wall Street's penalty box.

7 Growth Stocks to Buy and Hold Forever: January 2024

By Jeremy Flint, InvestorPlace Contributor
Growth stocks haven't kept up with wider market growth, creating a unique opportunity to capture long-term upside with these companies.
Load More Articles